Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology
|
September 20, 2015
Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer
Guillaume Margaillan, Éric Lévesque, Chantal Guillemette
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 4, 2013
Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing
Vincent Ménard, Pierre Collin, Guillaume Margaillan, et al.
Expert Review of Respiratory Medicine
|
February 1, 2013
The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future
Simon Malenfant, Guillaume Margaillan, Jérémy Edwin Loehr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 5, 2015
Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues
Guillaume Margaillan, Michèle Rouleau, John K Fallon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 17, 2015
Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, et al.
Trends in Biochemical Sciences
|
January 15, 2019
The Tumor Suppressor PALB2: Inside Out
Mandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Viruses
|
August 29, 2024
Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022
Bluma G Brenner, Ruxandra-Ilinca Ibanescu, Maureen Oliveira, et al.
Nucleic Acids Research
|
October 6, 2019
A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor
Amélie Rodrigue, Guillaume Margaillan, Thiago Torres Gomes, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Journal of Steroid Biochemistry and Molecular Biology
|
September 20, 2015
Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer
Guillaume Margaillan, Éric Lévesque, Chantal Guillemette
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 4, 2013
Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing
Vincent Ménard, Pierre Collin, Guillaume Margaillan, et al.
Expert Review of Respiratory Medicine
|
February 1, 2013
The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future
Simon Malenfant, Guillaume Margaillan, Jérémy Edwin Loehr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 5, 2015
Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues
Guillaume Margaillan, Michèle Rouleau, John K Fallon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 17, 2015
Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, et al.
Trends in Biochemical Sciences
|
January 15, 2019
The Tumor Suppressor PALB2: Inside Out
Mandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Viruses
|
August 29, 2024
Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022
Bluma G Brenner, Ruxandra-Ilinca Ibanescu, Maureen Oliveira, et al.
Nucleic Acids Research
|
October 6, 2019
A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor
Amélie Rodrigue, Guillaume Margaillan, Thiago Torres Gomes, et al.
Page
of 1